Creative Medical Technology Holdings, Inc. Stock
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.35 USD | -1.14% | +1.38% | -4.56% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 563K | Capitalization | 5.97M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | -4M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 * |
-1.34
x | P/E ratio 2025 * |
-1.71
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.05% |
1 day | -1.14% | ||
1 week | +1.38% | ||
Current month | -0.90% | ||
1 month | -8.72% | ||
3 months | +9.18% | ||
6 months | +0.23% | ||
Current year | -4.56% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-05-17 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 21-12-01 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Executive Officer | 63 | 16-05-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 4.4 | -0.11% | 4 527 |
24-05-22 | 4.405 | +0.11% | 542 |
24-05-21 | 4.4 | +2.32% | 6,359 |
24-05-20 | 4.3 | -3.37% | 5,103 |
24-05-17 | 4.45 | +2.53% | 2,137 |
Delayed Quote Nasdaq, May 23, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.56% | 5.97M | |
+10.89% | 116B | |
+12.04% | 106B | |
-6.50% | 23.89B | |
-3.17% | 21.58B | |
-11.25% | 18.96B | |
-40.50% | 16.96B | |
-14.88% | 16.33B | |
+6.33% | 14.14B | |
+33.04% | 12.02B |
- Stock Market
- Equities
- CELZ Stock